secpho

secpho

Collaborate to innovate

  • Open Innovation Club
  • Contact
  • We are
  • We connect
  • We transform
  • Join our ecosystem
  • Agenda
  • Become a member
  • Esp
  • Eng

LASERCOLEST

Technology:
Area: Health, demographic change and wellbeing.
SDG: Good health and well-being.
Developed by:
#
#
#
#
#
#
#
#
#
#

Reducing cholesterol levels non-drug and non-invasively with revolutionary laser treatment

LASERCOLEST is this pioneering healthcare initiative that combines scientific advances with the urgent need for innovative solutions to address hypercholesterolemia.

The project is the result of the collaboration of a consortium formed by the Institute of Photomedicine, Radiantis, Alter Technology, Draco Systems and Vidorreta Design, with the coordination of secpho. It also builds on recent research, such as that carried out by scientists at the University of Kansas, which has explored ultrasound-assisted laser techniques for the treatment of cholesterol, demonstrating significant advances in the safe and effective destruction of plaque.

The initiative has received funding from the Ministry of Industry, Trade and Tourism corresponding to Next Generation EU funds, canalised through the support programme for Innovative Business Groups, whose objective is to digitalise industry.

The current method of treatment, based on lifestyle changes and medications, has significant limitations.

The accumulation of fat in the blood vessels is to blame for many of the heart attacks and cardiovascular diseases that cause so many problems in our society. We could say that hypercholesterolemia is one of the silent epidemics of this century. Caused by the changes in diet and sedentary habits that appeared in the final decades of the 20th century, but also by hereditary genetic causes (so that some of those who suffer from it do so from childhood), hypercholesterolemia is one of the three main causes of cardiovascular disease (the main cause of death in men and women) as well as obesity and type II diabetes.

Cholesterol reduction is therefore a major concern for our society due to the high prevalence of cardiovascular disease worldwide. The current method of treatment, based on lifestyle changes and medications, has significant limitations, especially in pediatric populations.

The LASERCOLEST project seeks to fill this gap by offering an innovative and safe solution to reduce cholesterol levels through non-invasive laser therapy. Furthermore, this type of therapy could be implemented in both hospital and home settings, providing flexibility in the treatment of hypercholesterolemia in individuals of all ages and with any genetic predisposition.

The proposed laser therapy not only promises to be a safe alternative with no side effects, but is also envisioned as a personalized option compatible with other treatment approaches.

The central objective is to develop a medical device capable of destroying low-density lipid vesicles in cholesterol-carrying lipoproteins through the application of femtosecond transcutaneous lasers. The approach is based on Selective Photothermolysis, supported by scientific research demonstrating the ability of laser pulses to selectively fragment fat microvesicles without affecting the surrounding tissue.

The proposed technology uses a laser with a specific wavelength in the near infrared, which coincides with the absorption peaks of lipids in the blood. This approach is complemented by the ability to control the depth at which the breakthrough effect is generated, allowing the therapy to be directed into the blood vessels without affecting other tissues.

With this backing of strategic partners and a solid scientific basis, the project has developed a prototype demonstrator tested ex vivo on blood samples to demonstrate quantitative changes in cholesterol levels by laser application. As this is a research project, further progress must be made in testing the most suitable laser spectrum so that the reduction in cholesterol is significant.

In short, the consortium has tackled this novel application in which it will continue its research to improve the quality of life and offer effective and safe alternatives for the global population.

Other projects and success stories

SILICON EYE
SILICON EYE
UWB radar system for in-situ snow thickness measurement
UWB radar system for in-situ snow thickness measurement
Shape Sensing Project
Shape Sensing Project
Quantum for Cybersecurity
Quantum for Cybersecurity
Q LEAF PRO
Q LEAF PRO
TRAIN SCS
TRAIN SCS
TRY FIRST COMPACT
TRY FIRST COMPACT
Intelligent monitoring of containers at the Port of Barcelona
Intelligent monitoring of containers at the Port of Barcelona
Strechbio
Strechbio
PLATFORFUTURE
PLATFORFUTURE
DRONSTORE
DRONSTORE
ECO-PILOT
ECO-PILOT
PROVIDENTIAL
PROVIDENTIAL
BEACON
BEACON
AI to predict the performance of organic solar cells
AI to predict the performance of organic solar cells
SIARA Project
SIARA Project
HV INSPECT
HV INSPECT
SPECTROMEAT
SPECTROMEAT
OPTILASER
OPTILASER
CLAUDIT
CLAUDIT
OPTIENERGY
OPTIENERGY
SKINSENS
SKINSENS
DEVIFO Project
DEVIFO Project
LOGISDA Project
LOGISDA Project
DRONSTORE II
DRONSTORE II
Sensocell
Sensocell
SMART TEXTILE
SMART TEXTILE
SMARTFAB
SMARTFAB
Intelligent and sustainable urban logistics
Intelligent and sustainable urban logistics
SECLUREFA
SECLUREFA
Q LEAF IN VITRO
Q LEAF IN VITRO
Space Giganet
Space Giganet
HERMES
HERMES
SEPTIBELL
SEPTIBELL
Hexapods to align photonic components automatically
Hexapods to align photonic components automatically
WATERSENSE
WATERSENSE
Silicon technology in the fight against Covid-19
Silicon technology in the fight against Covid-19
TRY FIRST
TRY FIRST
AUTODRON
AUTODRON
Insense Project
Insense Project
Would you like
to get to know us better?
Contact us
Technological innovation?
Subscribe to our newsletter.
We are looking for talent.
Take a look at our job board.

  • Privacy policy
  • Cookies policy
  • Ethics Channel
  • Contact
© secpho 2025 | web: mafsdisseny